Related Experiment Video
Updated: Aug 2, 2026
10:36
In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
Published on: March 21, 2017
Bioequivalency comparison between two gonadotropin-releasing hormone products
R D Stevens1, B E Seguin, R L Hegstad
1Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul 55108, USA.
American Journal of Veterinary Research
|March 1, 1995
Summary
Two gonadotropin-releasing hormone (GnRH) preparations, gonadorelin diacetate tetrahydrate and gonadorelin semicarbonate, demonstrated bioequivalency in releasing luteinizing hormone (LH) in dairy cows. This finding supports their interchangeable use in reproductive management.
Area of Science:
- Veterinary Endocrinology
- Reproductive Physiology
Background:
- Gonadotropin-releasing hormone (GnRH) is crucial for regulating the estrous cycle in cattle.
- Two GnRH preparations, gonadorelin diacetate tetrahydrate and gonadorelin semicarbonate, are available for use in dairy cows.
- Understanding the bioequivalency of these preparations is important for effective reproductive management.
Purpose of the Study:
- To compare the bioequivalency of gonadorelin diacetate tetrahydrate and gonadorelin semicarbonate.
- To assess the luteinizing hormone (LH)-releasing ability of two GnRH products in diestrous dairy cows.
- To determine if differences exist in the LH release profiles between the two GnRH preparations.
Main Methods:
- A double-crossover design study was conducted with 24 cycling Holstein cows.
- Estrus synchronization was achieved using a double prostaglandin treatment.
- Cows received single 100-microgram doses of either GnRH preparation, with serum LH concentrations measured at multiple time points post-treatment.
Main Results:
- No significant differences were observed between the two GnRH products regarding mean LH concentration over 24 hours.
- Maximal LH concentration, time to maximal LH concentration, and the area under the LH concentration curve did not differ significantly.
- The LH release patterns following administration of both GnRH preparations were comparable.
Conclusions:
- The study confirms the bioequivalency of gonadorelin diacetate tetrahydrate and gonadorelin semicarbonate.
- Both GnRH preparations exhibit similar LH-releasing abilities in diestrous dairy cows.
- The findings support the interchangeable use of these two GnRH products in cattle reproductive protocols.
Related Concept Videos
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
01:17Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...